Author

Peter B. Gilbert

174 papers · 1979–2026

1979peak 13 in 20102026

Frequent co-authors

Papers

showing 1–25 of 174 RSS

TaintDroid: an information-flow tracking system for realtime privacy monitoring on smartphones

William Enck, Peter Gilbert, Byung-Gon Chun +4 more

Signal Processing · Operating Systems Design and Implementation · 4 Oct 2010 · cited 2,288× · DOI ↗ · more like this ·

Today’s smartphone operating systems frequently fail to provide users with adequate control over and visibility into how third-party applications use their private data. We address these shortcomings with TaintDroid, an efficient, system-wide dynamic taint tracking and analysis system capable of simultaneously tracking multiple sources of sensitive data. TaintDroid provides realtime analysis by leveraging Android’s virtualized execution environment. TaintDroid incurs only 14 % performance overhead on a CPU-bound micro-benchmark and imposes negligible overhead on interactive third-party applications. Using TaintDroid to monitor the behavior of 30 popular third-party Android applications, we found 68 instances of potential misuse of users ’ private information across 20 applications. Monitoring sensitive data with TaintDroid provides informed use of third-party applications for phone…

TaintDroid

William Enck, Peter Gilbert, Seungyeop Han +6 more

Signal Processing · ACM Transactions on Computer Systems · June 2014 · cited 1,176× · DOI ↗ · more like this ·

Today’s smartphone operating systems frequently fail to provide users with visibility into how third-party applications collect and share their private data. We address these shortcomings with TaintDroid, an efficient, system-wide dynamic taint tracking and analysis system capable of simultaneously tracking multiple sources of sensitive data. TaintDroid enables realtime analysis by leveraging Android’s virtualized execution environment. TaintDroid incurs only 32% performance overhead on a CPU-bound microbenchmark and imposes negligible overhead on interactive third-party applications. Using TaintDroid to monitor the behavior of 30 popular third-party Android applications, in our 2010 study we found 20 applications potentially misused users’ private information; so did a similar fraction of the tested applications in our 2012 study. Monitoring the flow of privacy-sensitive data with…

chngpt: threshold regression model estimation and inference

Youyi Fong, Ying Huang, Peter B. Gilbert +1 more

Statistics and Probability · BMC Bioinformatics · 16 Oct 2017 · cited 292× · DOI ↗ · more like this ·

BACKGROUND: Threshold regression models are a diverse set of non-regular regression models that all depend on change points or thresholds. They provide a simple but elegant and interpretable way to model certain kinds of nonlinear relationships between the outcome and a predictor. RESULTS: The R package chngpt provides both estimation and hypothesis testing functionalities for four common variants of threshold regression models. All allow for adjustment of additional covariates not subjected to thresholding. We demonstrate the consistency of the estimating procedures and the type 1 error rates of the testing procedures by Monte Carlo studies, and illustrate their practical uses using an example from the study of immune response biomarkers in the context of Mother-To-Child-Transmission of HIV-1 viruses. CONCLUSION: chngpt makes several unique contributions to the software for threshold…

Evaluating Candidate Principal Surrogate Endpoints

Peter B. Gilbert, Michael G. Hudgens

Statistics and Probability · Biometrics · 24 Mar 2008 · cited 184× · DOI ↗ · more like this ·

SUMMARY: Frangakis and Rubin (2002, Biometrics 58, 21-29) proposed a new definition of a surrogate endpoint (a "principal" surrogate) based on causal effects. We introduce an estimand for evaluating a principal surrogate, the causal effect predictiveness (CEP) surface, which quantifies how well causal treatment effects on the biomarker predict causal treatment effects on the clinical endpoint. Although the CEP surface is not identifiable due to missing potential outcomes, it can be identified by incorporating a baseline covariate(s) that predicts the biomarker. Given case-cohort sampling of such a baseline predictor and the biomarker in a large blinded randomized clinical trial, we develop an estimated likelihood method for estimating the CEP surface. This estimation assesses the "surrogate value" of the biomarker for reliably predicting clinical treatment effects for the same or…

Toward trustworthy mobile sensing

Peter Gilbert, Landon P. Cox, Jaeyeon Jung +1 more

Information Systems · 2010 · cited 166× · DOI ↗ · more like this ·

Commodity mobile devices have been utilized as sensor nodes in a variety of domains, including citizen journalism, mobile social services, and domestic eldercare. In each of these domains, data integrity and device-owners' privacy are first-class concerns, but current approaches to secure sensing fail to balance these properties. External signing infrastructure cannot attest to the values generated by a device's sensing hardware, while trusted sensing hardware does not allow users to securely reduce the fidelity of readings in order to preserve their privacy. In this paper we examine the challenges posed by the potentially conflicting goals of data integrity and user privacy and propose a trustworthy mobile sensing platform which leverages inexpensive commodity Trusted Platform Module (TPM) hardware.

Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials

Peter B. Gilbert, Ronald J. Bosch, Michael G. Hudgens

Statistics and Probability · Biometrics · 26 Aug 2003 · cited 163× · DOI ↗ · more like this ·

Vaccines with limited ability to prevent HIV infection may positively impact the HIV/AIDS pandemic by preventing secondary transmission and disease in vaccine recipients who become infected. To evaluate the impact of vaccination on secondary transmission and disease, efficacy trials assess vaccine effects on HIV viral load and other surrogate endpoints measured after infection. A standard test that compares the distribution of viral load between the infected subgroups of vaccine and placebo recipients does not assess a causal effect of vaccine, because the comparison groups are selected after randomization. To address this problem, we formulate clinically relevant causal estimands using the principal stratification framework developed by Frangakis and Rubin (2002, Biometrics 58, 21-29), and propose a class of logistic selection bias models whose members identify the estimands. Given a…

Vision

Peter Gilbert, Byung-Gon Chun, Landon P. Cox +1 more

Signal Processing · 28 Jun 2011 · cited 156× · DOI ↗ · more like this ·

Smartphones and "app" markets are raising concerns about how third-party applications may misuse or improperly handle users' privacy-sensitive data. Fortunately, unlike in the PC world, we have a unique opportunity to improve the security of mobile applications thanks to the centralized nature of app distribution through popular app markets. Thorough validation of apps applied as part of the app market admission process has the potential to significantly enhance mobile device security. In this paper, we propose AppInspector, an automated security validation system that analyzes apps and generates reports of potential security and privacy violations. We describe our vision for making smartphone apps more secure through automated validation and outline key challenges such as detecting and analyzing security and privacy violations, ensuring thorough test coverage, and scaling to large…

Comparison of HIV‐1 and HIV‐2 infectivity from a prospective cohort study in Senegal

Peter B. Gilbert, Ian W. McKeague, Geoffrey Eisen +4 more

Sociology and Political Science · Statistics in Medicine · 28 Jan 2003 · cited 150× · DOI ↗ · more like this ·

From a prospective cohort study of 1948 initially human immunodeficiency virus (HIV) uninfected female commercial sex workers followed between 1985 and 1999 in Dakar, Senegal, the authors compared the male to female per infectious sexual exposure transmission probability of HIV types one (HIV-1) and two (HIV-2). New non-parametric competing risks failure time methods were used, which minimized modelling assumptions and controlled for risk factors for HIV infection. The HIV-1 versus HIV-2 infectivity ratio over time was estimated by the ratio of smoothed non-parametric kernel estimates of the HIV-1 and HIV-2 infection hazard functions in sex workers, adjusted by an estimate of the relative HIV-1 versus HIV-2 prevalence in the partner population. HIV-1 was found to be significantly more infectious than HIV-2 throughout the follow-up period (P < 0.001). The HIV-1/HIV-2 infectivity ratio…

Doubly robust nonparametric inference on the average treatment effect

David Benkeser, Marco Carone, Mark J. van der Laan +1 more

Statistics and Probability · Biometrika · 11 Sep 2017 · cited 138× · DOI ↗ · more like this ·

Doubly robust estimators are widely used to draw inference about the average effect of a treatment. Such estimators are consistent for the effect of interest if either one of two nuisance parameters is consistently estimated. However, if flexible, data-adaptive estimators of these nuisance parameters are used, double robustness does not readily extend to inference. We present a general theoretical study of the behaviour of doubly robust estimators of an average treatment effect when one of the nuisance parameters is inconsistently estimated. We contrast different methods for constructing such estimators and investigate the extent to which they may be modified to also allow doubly robust inference. We find that while targeted minimum loss-based estimation can be used to solve this problem very naturally, common alternative frameworks appear to be inappropriate for this purpose. We…

A general framework for inference on algorithm-agnostic variable importance

Brian D. Williamson, Peter B. Gilbert, Noah R. Simon +1 more

stat.ME · April 2020 · cited 121× · arXiv ↗ · more like this ·

In many applications, it is of interest to assess the relative contribution of features (or subsets of features) toward the goal of predicting a response -- in other words, to gauge the variable importance of features. Most recent work on variable importance assessment has focused on describing the importance of features within the confines of a given prediction algorithm. However, such assessment does not necessarily characterize the prediction potential of features, and may provide a misleading reflection of the intrinsic value of these features. To address this limitation, we propose a general framework for nonparametric inference on interpretable algorithm-agnostic variable importance. We define variable importance as a population-level contrast between the oracle predictiveness of all available features versus all features except those under consideration. We propose a…

Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials

Peter B. Gilbert

Artificial Intelligence · Biometrika · March 1999 · cited 120× · DOI ↗ · more like this ·

Journal Article Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials Get access PB Gilbert, PB Gilbert Search for other works by this author on: Oxford Academic Google Scholar SR Lele, SR Lele Search for other works by this author on: Oxford Academic Google Scholar Y Vardi Y Vardi Search for other works by this author on: Oxford Academic Google Scholar Biometrika, Volume 86, Issue 1, March 1999, Pages 27–43, https://doi.org/10.1093/biomet/86.1.27 Published: 01 March 1999

Nonparametric variable importance assessment using machine learning techniques

Brian D. Williamson, Peter B. Gilbert, Marco Carone +1 more

Statistics and Probability · Biometrics · 12 Oct 2020 · cited 107× · DOI ↗ · more like this ·

In a regression setting, it is often of interest to quantify the importance of various features in predicting the response. Commonly, the variable importance measure used is determined by the regression technique employed. For this reason, practitioners often only resort to one of a few regression techniques for which a variable importance measure is naturally defined. Unfortunately, these regression techniques are often suboptimal for predicting the response. Additionally, because the variable importance measures native to different regression techniques generally have a different interpretation, comparisons across techniques can be difficult. In this work, we study a variable importance measure that can be used with any regression technique, and whose interpretation is agnostic to the technique used. This measure is a property of the true data-generating mechanism. Specifically, we…

Nonparametric Bounds and Sensitivity Analysis of Treatment Effects

Amy Richardson, Michael G. Hudgens, Peter B. Gilbert +1 more

stat.ME · 5 Mar 2015 · cited 77× · arXiv ↗ · more like this ·

This paper considers conducting inference about the effect of a treatment (or exposure) on an outcome of interest. In the ideal setting where treatment is assigned randomly, under certain assumptions the treatment effect is identifiable from the observable data and inference is straightforward. However, in other settings such as observational studies or randomized trials with noncompliance, the treatment effect is no longer identifiable without relying on untestable assumptions. Nonetheless, the observable data often do provide some information about the effect of treatment, that is, the parameter of interest is partially identifiable. Two approaches are often employed in this setting: (i) bounds are derived for the treatment effect under minimal assumptions, or (ii) additional untestable assumptions are invoked that render the treatment effect identifiable and then sensitivity analysis…

Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop

Christopher S. Coffey, Bruce Levin, Christina Clark +4 more

Statistics and Probability · Clinical Trials · December 2012 · cited 77× · DOI ↗ · more like this ·

BACKGROUND: The clinical trials community has a never-ending search for dependable and reliable ways to improve clinical research. This exploration has led to considerable interest in adaptive clinical trial designs, which provide the flexibility to adjust trial characteristics on the basis of data reviewed at interim stages. Statisticians and clinical investigators have proposed or implemented a wide variety of adaptations in clinical trials, but specific approaches have met with differing levels of support. Within industry, investigators are actively exploring the benefits and pitfalls associated with adaptive designs (ADs). For example, a Drug Information Association (DIA) working group on ADs has engaged regulatory agencies in discussions. Many researchers working on publicly funded clinical trials, however, are not yet fully engaged in this discussion. We organized the Scientific…

Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials

Bryan E. Shepherd, Peter B. Gilbert, Yannis Jemiai +1 more

Statistics and Probability · Biometrics · 15 Dec 2005 · cited 76× · DOI ↗ · more like this ·

In many experiments, researchers would like to compare between treatments and outcome that only exists in a subset of participants selected after randomization. For example, in preventive HIV vaccine efficacy trials it is of interest to determine whether randomization to vaccine causes lower HIV viral load, a quantity that only exists in participants who acquire HIV. To make a causal comparison and account for potential selection bias we propose a sensitivity analysis following the principal stratification framework set forth by Frangakis and Rubin (2002, Biometrics58, 21-29). Our goal is to assess the average causal effect of treatment assignment on viral load at a given baseline covariate level in the always infected principal stratum (those who would have been infected whether they had been assigned to vaccine or placebo). We assume stable unit treatment values (SUTVA)…

Hypersonic Boundary-Layer Transition Experiments in a Mach-6 Quiet Tunnel

Dennis C. Berridge, Amanda Chou, Chris Ward +5 more

Applied Mathematics · 48th AIAA Aerospace Sciences Meeting Including the New Horizons Forum and Aerospace Exposition · 4 Jan 2010 · cited 64× · DOI ↗ · more like this ·

The Boeing/AFOSR Mach-6 Quiet Tunnel has achieved quiet flow to stagnation pressures of 146 psia, and intermittently quiet flow between 146 and 169 psia. In an attempt to measure natural transition under quiet flow, a 3-m-circular-arc compression cone was tested with a nearly sharp nosetip. Using temperature-sensitive paint, hot streaks were observed to develop near the rear of the cone at high pressures under quiet flow. The streaks do not appear under noisy flow. The cause of the hot streaks remains unknown, though they may be instabilities or artifacts of nonlinear breakdown. Under quiet flow, the cone boundary layer remained laminar up to N factors of at least 15 and possibly as high as 19. Transition occurred at N = 9 under noisy flow. It is unknown why laminar flow persisted to such high N factors. As part of an investigation of crossflow vortices, a 7 half-angle cone was tested…

Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials

JoAnna M. Scott, Allan C. deCamp, Michal Juraska +2 more

Statistics and Probability · Statistical Methods in Medical Research · 29 Sep 2014 · cited 63× · DOI ↗ · more like this ·

Stepped wedge designs are increasingly commonplace and advantageous for cluster randomized trials when it is both unethical to assign placebo, and it is logistically difficult to allocate an intervention simultaneously to many clusters. We study marginal mean models fit with generalized estimating equations for assessing treatment effectiveness in stepped wedge cluster randomized trials. This approach has advantages over the more commonly used mixed models that (1) the population-average parameters have an important interpretation for public health applications and (2) they avoid untestable assumptions on latent variable distributions and avoid parametric assumptions about error distributions, therefore, providing more robust evidence on treatment effects. However, cluster randomized trials typically have a small number of clusters, rendering the standard generalized estimating equation…

YouProve

Peter Gilbert, Jaeyeon Jung, Kyungmin Lee +4 more

Signal Processing · November 2011 · cited 63× · DOI ↗ · more like this ·

As more services have come to rely on sensor data such as audio and photos collected by mobile phone users, verifying the authenticity of this data has become critical for service correctness. At the same time, clients require the flexibility to tradeoff the fidelity of the data they contribute for resource efficiency or privacy. This paper describes YouProve, a partnership between a mobile device's trusted hardware and software that allows untrusted client applications to directly control the fidelity of data they upload and services to verify that the meaning of source data is preserved. The key to our approach is trusted analysis of derived data, which generates statements comparing the content of a derived data item to its source. Experiments with a prototype implementation for Android demonstrate that YouProve is feasible. Our photo analyzer is over 99% accurate at identifying…

Comparing Biomarkers as Principal Surrogate Endpoints

Ying Huang, Peter B. Gilbert

Statistics and Probability · Biometrics · 22 Apr 2011 · cited 63× · DOI ↗ · more like this ·

Recently a new definition of surrogate endpoint, the "principal surrogate," was proposed based on causal associations between treatment effects on the biomarker and on the clinical endpoint. Despite its appealing interpretation, limited research has been conducted to evaluate principal surrogates, and existing methods focus on risk models that consider a single biomarker. How to compare principal surrogate value of biomarkers or general risk models that consider multiple biomarkers remains an open research question. We propose to characterize a marker or risk model's principal surrogate value based on the distribution of risk difference between interventions. In addition, we propose a novel summary measure (the standardized total gain) that can be used to compare markers and to assess the incremental value of a new marker. We develop a semiparametric estimated-likelihood method to…

Endpoints in vaccine trials

Michael G. Hudgens, Peter B. Gilbert, Steven G. Self

Health · Statistical Methods in Medical Research · April 2004 · cited 63× · DOI ↗ · more like this ·

In this paper we discuss statistical considerations regarding endpoints in preventive vaccine trials. Brief discussion is given to preclinical, Phase I, and Phase II trials, with the bulk of attention paid to endpoint choice and analysis in Phase III efficacy trials. In addition to traditional efficacy measures of vaccine effects for immunized individuals, consideration is given to waning, strain specific efficacy, correlates of protective immunity, postinfection endpoints, and cluster randomized trials.

Statistical Methods for Assessing Differential Vaccine Protection Against Human Immunodeficiency Virus Types

Peter B. Gilbert, Steven G. Self, Mark Ashby

Statistics and Probability · Biometrics · September 1998 · cited 57× · DOI ↗ · more like this ·

The human immunodeficiency virus type 1 (HIV-1) is extremely diverse. In assessing the utility of an HIV-1 vaccine, an important issue is the possibility of differential protection. We discuss statistical methods of inferring how the vaccine efficacy may vary with viral type from data that would be collected from a randomized, double-blind, placebo-controlled preventive vaccine efficacy trial. Detailed characterization of virus isolated from individuals infected during the trial will be available. We focus on the highly simplified case in which the viral characteristics are summarized by a single feature, which may be nominal, or a scalar quantity that represents distance between the isolate and the prototype virus or viruses used in the vaccine preparation. We consider discrete categorical and continuous response models for this quantity and identify models whose parameters can be…

Assessing Treatment‐Selection Markers using a Potential Outcomes Framework

Ying Huang, Peter B. Gilbert, Holly Janes

Statistics and Probability · Biometrics · 2 Feb 2012 · cited 56× · DOI ↗ · more like this ·

Treatment-selection markers are biological molecules or patient characteristics associated with one's response to treatment. They can be used to predict treatment effects for individual subjects and subsequently help deliver treatment to those most likely to benefit from it. Statistical tools are needed to evaluate a marker's capacity to help with treatment selection. The commonly adopted criterion for a good treatment-selection marker has been the interaction between marker and treatment. While a strong interaction is important, it is, however, not sufficient for good marker performance. In this article, we develop novel measures for assessing a continuous treatment-selection marker, based on a potential outcomes framework. Under a set of assumptions, we derive the optimal decision rule based on the marker to classify individuals according to treatment benefit, and characterize the…

Large sample theory of maximum likelihood estimates in semiparametric biased sampling models

Peter B. Gilbert

Statistics and Probability · The Annals of Statistics · February 2000 · cited 56× · DOI ↗ · more like this ·

Vardi [Ann.Statist.13 178-203 (1985)] introduced an $s$-sample biased sampling model with known selection weight functions, gave a condition under which the common underlying probability distribution $G$ is uniquely estimable and developed simple procedure for computing the nonparametric maximum likelihood estimator (NPMLE) $\mathbb{G}_n$ of $G$. Gill, Vardi and Wellner thoroughly described the large sample properties of Vardi’s NPMLE, giving results on uniform consistency, convergence of $\sqrt{n}(\mathbb{G}-G)$ to a Gaussian process and asymptotic efficiency of $\mathbb{G}_n$. Gilbert, Lele and Vardi considered the class of semiparametric $s$-sample biased sampling models formed by allowing the weight functions to depend on an unknown finite-dimensional parameter $\theta$ .They extended Vardi’s estimation approach by developing a simple two-step estimation procedure in which…

A Comparison of Eight Methods for the Dual‐Endpoint Evaluation of Efficacy in a Proof‐of‐Concept HIV Vaccine Trial

Devan V. Mehrotra, Xiaoming Li, Peter B. Gilbert

Statistics and Probability · Biometrics · February 2006 · cited 54× · DOI ↗ · more like this ·

To support the design of the world's first proof-of-concept (POC) efficacy trial of a cell-mediated immunity-based HIV vaccine, we evaluate eight methods for testing the composite null hypothesis of no-vaccine effect on either the incidence of HIV infection or the viral load set point among those infected, relative to placebo. The first two methods use a single test applied to the actual values or ranks of a burden-of-illness (BOI) outcome that combines the infection and viral load endpoints. The other six methods combine separate tests for the two endpoints using unweighted or weighted versions of the two-part z, Simes', and Fisher's methods. Based on extensive simulations that were used to design the landmark POC trial, the BOI methods are shown to have generally low power for rejecting the composite null hypothesis (and hence advancing the vaccine to a subsequent large-scale efficacy…

Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials

Julian Wolfson, Peter B. Gilbert

Statistics and Probability · Biometrics · 22 Jan 2010 · cited 52× · DOI ↗ · more like this ·

Given a randomized treatment Z, a clinical outcome Y, and a biomarker S measured some fixed time after Z is administered, we may be interested in addressing the surrogate endpoint problem by evaluating whether S can be used to reliably predict the effect of Z on Y. Several recent proposals for the statistical evaluation of surrogate value have been based on the framework of principal stratification. In this article, we consider two principal stratification estimands: joint risks and marginal risks. Joint risks measure causal associations (CAs) of treatment effects on S and Y, providing insight into the surrogate value of the biomarker, but are not statistically identifiable from vaccine trial data. Although marginal risks do not measure CAs of treatment effects, they nevertheless provide guidance for future research, and we describe a data collection scheme and assumptions under which…